Arvaya Healthcare share news, announcements and annual reports
BSE: 524723Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹111.10.
30 Oct: open ₹113.30, high ₹113.30, low ₹113.30
- The board meets on 4 Nov 2026. Every company's board meetings
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹588 Cr2,703rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.17
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 250
Arvaya Healthcare share news and announcements
530 announcements, routine notices left out, newest first. Page 6 of 11.
Oct 2023
12 Oct · Compliance-57 (5) : intimation after the end of quarter
Sep 2023
30 Sep · Management
30 Sep · Management
30 Sep · Meeting
30 Sep · Meeting
Aug 2023
26 Aug · Meeting
26 Aug · Meeting
14 Aug · Results
11 Aug · Announcement under Regulation 30 (LODR)-Change in RTA
4 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results4 Aug · Management
Jul 2023
5 Jul · Compliance-57 (5) : intimation after the end of quarter
Jun 2023
May 2023
30 May · Non Applicability Of Regulation 23(9) Of SEBI (LODR) (Amendment) Regulations, 2015
30 May · Results
23 May · Board meeting
Meeting on 30 May 2023: audited results
Apr 2023
20 Apr · Compliance Certificate For The Year Ended 31St March, 2023
18 Apr · Compliance Certificate For The Year Ended 31St March, 2023
Feb 2023
6 Feb · Results
1 Feb · Management
1 Feb · Change In Address Of Registrar And Share Transfer Agent
1 Feb · Results
Jan 2023
23 Jan · Board meeting
Meeting on 1 Feb 2023: quarterly results
Nov 2022
14 Nov · Results
Oct 2022
31 Oct · Board meeting
Meeting on 14 Nov 2022: quarterly results11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
28 Sep · Meeting
28 Sep · Meeting
Aug 2022
25 Aug · Reg. 34 (1) Annual Report.
25 Aug · Meeting
22 Aug · Corporate action
3 Aug · Results
Jul 2022
25 Jul · Board meeting
Meeting on 3 Aug 2022: quarterly results11 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2022
30 May · Board meeting
16 May · Board meeting
Meeting on 30 May 2022: audited results
Apr 2022
20 Apr · Compliance For The Year Ended 31.03.2022
18 Apr · Compliance Certificate For The Period Ended 31St March, 2022
18 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2022
8 Feb · Results
Jan 2022
25 Jan · Board meeting
Meeting on 8 Feb 2022: quarterly results14 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....